The company said that with proper funding , ABthrax could be available for emergency use as early as the end of 2004 .
Human Genome said ABthrax could be available for emergency use as early as the end of 2004 .
One , from a former CIBC executive , described the returns earned by the bank on its Enron deals as " outrageous . "